Microbe Profile: Saccharopolyspora erythraea: antibiotic factory and biosynthetic model organism.

Saccharopolyspora erythraea is a filamentous actinomycete best known as the industrial source of erythromycin, a macrolide antibiotic that remains an important medicine and precursor for the semisynthetic drugs clarithromycin and azithromycin. Beyond its industrial importance, S. erythraea has had a profound influence on natural product bioscience. Studies of erythromycin biosynthesis led to the discovery of modular polyketide synthases and established the principles of assembly-line enzymatic logic that underpin modern understanding of microbial polyketide biosynthesis. Consequently, S. erythraea has served both as an antibiotic production platform and as a model organism for investigating and engineering complex biosynthetic pathways. Continued efforts to understand its metabolism, genetic changes during strain improvement, and the reprogramming of its polyketide synthase machinery are expected to support the development of next-generation antibiotics and biotechnological applications.